Trusted Diagnostic Technology

microRNA, FISH, AND NEXT-GENERATION SEQUENCING

The RosettaGX™ platform of tests uses blended technology platforms (microRNA, FISH, Next-Generation Sequencing) along with proprietary scientific approaches for each tumor type in our offering. We choose the most clinically informative and relevant testing based on an ongoing and thorough review of scientific literature and an internal medical review process

Rosetta Genomics is advancing and developing multiple diagnostic programs in cancer and for various other indications to enable accurate diagnosis and prognosis, and improve patient care management worldwide.